Literature DB >> 12487784

Comparison of the pharmacological mechanisms involved in the platelet lowering actions of anagrelide and hydroxyurea: a review.

Ying Hong1, Jorge D Erusalimsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12487784     DOI： 10.1080/0953710021000016339

Source DB:  PubMed          Journal:  Platelets        ISSN： 0953-7104            Impact factor:   3.862


× No keyword cloud information.
  4 in total

1.  Progression of bone marrow fibrosis in patients with essential thrombocythemia and polycythemia vera during anagrelide treatment.

Authors:  Magnus Hultdin; Gunnel Sundström; Anders Wahlin; Berith Lundström; Jan Samuelsson; Gunnar Birgegård; Anna Engström-Laurent
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

2.  Comparison of the biological activities of anagrelide and its major metabolites in haematopoietic cell cultures.

Authors:  Guosu Wang; Richard Franklin; Ying Hong; Jorge D Erusalimsky
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

Review 3.  Advances and challenges in the management of essential thrombocythemia.

Authors:  Gunnar Birgegård
Journal:  Ther Adv Hematol       Date:  2015-06

Review 4.  The Use of Anagrelide in Myeloproliferative Neoplasms, with Focus on Essential Thrombocythemia.

Authors:  Gunnar Birgegård
Journal:  Curr Hematol Malig Rep       Date:  2016-10       Impact factor: 3.952
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.